NNVC News | Roxom Stocks

Mkt Cap

$35.2M

Volume

147.23K

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

2 Small-Cap Biotechs That Could Reward Patient InvestorsThe article discusses two small-cap biotech companies with high-risk, high-potential investment opportunities: Mainz Biomed and NanoViricides. Both companies are developing innovative medical technologies but face significant financial challenges and are pre-revenue.Investing.com · Dec 12, 2025

Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving PremarketGainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday. Trinity Place Holdings Inc. (NYSE: TPHS) gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 20.8% to $0.54 in pre-market trading. NanoViricides, Inc. (NYSE: NNVC) rose 19.9% to $1.69 in pre-market trading. NanoViricides reported effectiveness of antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with respiratory syncytial virus. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares climbed 18.2% to $5.86 in pre-market trading. Acumen Pharmaceuticals recently announced it ...Benzinga · Jul 11, 2023

NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. NanoViricides is presenting on May 10th.GlobeNewswire Inc. · May 4, 2023

uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For TuesdayUBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market trading. Credit Suisse raised the price target for uniQure N.V. (NASDAQ: QURE) from $51 to $55. Credit Suisse analyst Judah Frommer maintained an Outperform rating on the stock. uniQure shares jumped 5.2% to close at $21.00 on Monday. Piper Sandler cut the price target for Dollar General Corporation (NYSE: DG) from $288 to $275. Piper Sandler analyst Peter Keith maintained an Overweight rating. Dollar General shares gained 1.4% to $219.11 in pre-market trading. EF Hutton slashed the price target for NanoViricides, Inc. (NYSE: Full story available on Benzinga.comBenzinga · Feb 28, 2023

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From YesterdayGainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash. Onion Global Limited (NYSE: OG) jumped 90.6% to close at $0.7624 on Thursday. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares surged 81% to close at $8.00 on Thursday after gaining over 12% on Wednesday. Minerva Neurosciences, Inc. (NASDAQ: NERV) gained 75.4% to close at $4.70. Missfresh Limited (NASDAQ: MF) shares climbed 51.7% to close at $0.1746 after dropping 7% on Wednesday. NanoViricides, Inc. (NYSE: NNVC) climbed 48.4% to close at $3.65 after the company announced it has begun drug development to combat Monkeypox virus. ZW Data Action Technologies Inc. (NASDAQ: CNET) jumped 44.4% to close at $0.83. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data. Yellow Corporation (NASDAQ: YELL) rose 42.2% to close at $6.70 after the company swung to a profit for the second quarter. Global Blood Therapeutics, Inc. (NASDAQ: GBT) gained 41.4% to close at $47.99 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal. Applied DNA Sciences, Inc. (NASDAQ: APDN) climbed 40% to settle at $5.74 as the company reported pricing of $12 million upsized offering. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares jumped 38.1% to settle at $0.1560 after gaining around 9% on Wednesday. Greenpro Capital Corp. (NASDAQ: GRNQ) gained 37.7% to close at $2.41 after climbing around 14% on Tuesday after climbing 28% on Wednesday. Quhuo Limited (NASDAQ: QH) rose 37.6% to close at $0.45. Forge Global Holdings, Inc. (NYSE: FRGE) jumped 33% to close at $6.05. Forge Global is expected to report Q2 financial results on August 11, 2022. Legacy Housing Corporation (NASDAQ: LEGH) jumped 30.4% to close at $17.62 after the company late Wednesday re-stated Q1, Q2 and Q3 interim financial statements for FY21. GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 30.3% to close at $3.57. Geovax Labs posted a Q2 loss of $0.21 per share. GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 27.6% to close at $4.16 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Waitr Holdings Inc. (NASDAQ: WTRH) jumped 26.9% to settle at $0.4288. Society Pass Incorporated (NASDAQ: SOPA) jumped 26.2% to close at $2.36 after reporting 2Q 2022 and 1H 2022 financial results. Exicure, Inc. (NASDAQ: XCUR) shares gained 25.6% to close at $2.50 after climbing around 27% on Wednesday. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 23.2% to close at $13.74 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program. Immunic, Inc. (NASDAQ: IMUX) gained 23.1% to close at $4.79 following Q2 results. PagSeguro Digital Ltd. (NYSE: PAGS) gained 22.9% to close at $15.03. TTM Technologies, Inc. (NASDAQ: TTMI) rose 22.4% to close at $16.53 following upbeat Q2 results. Altice USA, Inc. (NYSE: ATUS) surged 21.5% to close at $11.75 following strong quarterly sales. Amesite Inc. (NASDAQ: AMST) gained 20.9% to close at $0.52. Pintec Technology Holdings Limited (NASDAQ: PT) jumped 18.5% to close at $1.2201. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) jumped 18.8% to close at $0.2642. Precigen, Inc. (NASDAQ: PGEN) jumped 18.4% to settle at $2.12. Digital Brands Group, Inc. (NASDAQ: DBGI) rose 16.7% to close at $0.14. Digital Brands Group, last month, received a determination letter from the Nasdaq stating that the Company has not regained compliance. MercadoLibre, Inc. (NASDAQ: MELI) rose 16.2% to close at $1,034.83 following better-than-expected quarterly ...Benzinga · Aug 5, 2022

10 Top Monkeypox Stocks To Watch Right Now10 monkeypox stocks and monkeypox penny stocks to watch The post 10 Top Monkeypox Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Aug 4, 2022

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day SessionGainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556. ChemoCentryx, Inc. (NASDAQ: CCXI) gained 110% to $50.68 after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash. Minerva Neurosciences, Inc. (NASDAQ: NERV) jumped 80% to $4.8300. Greenpro Capital Corp. (NASDAQ: GRNQ) rose 61.1% to $2.82 after climbing around 14% on Tuesday after climbing 28% on Wednesday. Missfresh Limited (NASDAQ: MF) shares surged 59.3% to $0.1834 after dropping 7% on Wednesday. Quhuo Limited (NASDAQ: QH) gained 51.8% to $0.4966. Yellow Corporation (NASDAQ: YELL) rose 44.1% to $6.79 after the company swung to a profit for the second quarter. Society Pass Incorporated (NASDAQ: SOPA) gained 42.8% to $2.6700 after reporting 2Q 2022 and 1H 2022 financial results. GreenLight Biosciences Holdings (NASDAQ: GRNA) shares gained 39.6% to $4.55 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership. ZW Data Action Technologies Inc. (NASDAQ: CNET) surged 37.5% to $0.79. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data. Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 36.5% to $46.31 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal. Legacy Housing Corporation (NASDAQ: LEGH) rose 29.9% to $17.55. Legacy Housing will restate its 1st, 2nd, 3rd quarters unaudited interim financial statements for FY21, Reuters reported. Forge Global Holdings, Inc. (NYSE: FRGE) jumped 27.8% to $5.82. Forge Global is expected to report Q2 financial results on August 11, 2022. Molecular Data Inc. (NASDAQ: MKD) gained 26.3% to $0.7701. Waitr Holdings Inc. (NASDAQ: WTRH) surged 26% to $0.4267. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) gained 25.5% to $14.00 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares rose 25.5% to $0.1418 after gaining around 9% on Wednesday. Immunic, Inc. (NASDAQ: IMUX) gained 25% to $4.89 following Q2 results. NanoViricides, Inc. (NYSE: NNVC) jumped 23.5% to $3.04 after the company announced it has begun drug development to combat Monkeypox virus. Exela Technologies, Inc. (NASDAQ: XELA) rose 20.5% to $1.7594 after the company announced an update on its capital deployment strategy. Exela Technologies says the company has purchased $70 million of face value 2026 Senior Secured Notes at a discount with funds raised from equity. This will be the first contribution to the company's STS ("Serve the Shareholders") initiative. Ashford Inc. (NYSE: AINC) gained 20.1% to $16.78 following Q2 earnings. Staffing 360 Solutions, Inc. (NASDAQ: STAF) surged 20% to $3.8462. Synthetic Biologics, Inc. (NYSE: SYN) rose 19.4% to $1.77. Synthetic Biologics recently announced a $3 million private placement of convertible preferred stock. Eloxx Pharmaceuticals, Inc. (NASDAQ:Benzinga · Aug 4, 2022

EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 CandidateNanoViricides Inc (NYSE: NNVC) has developed oral gummies formulations of its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 to benefit non-hospitalized patients. What Happened: NanoViricides completed the development of an oral gummies (chewable gel) formulation of NV-CoV-2 for the benefit of symptomatic non-hospitalized patients. The Company believes that this formulation may have advantages in drug bioavailability over oral pills because of partial sublingual absorption that avoids the gastrointestinal tract. NanoViricides ...Benzinga · Nov 15, 2021

NanoViricides COVID-19 Treatment Candidate Found Effective Against Coronavirus Variants In Lab StudyShares of NanoViricides Inc (NYSE: NNVC), a developer of antiviral therapies based on a novel nanomedicines technology, are higher Monday. What Happened: NanoViricides said its pan-Coronavirus COVID-19 drug candidate, NV-CoV-2, was found to be effective against SARS-CoV-2 in a standard cell culture pseudovirion assay. "We have now demonstrated that NV-CoV-2 is highly effective in cell cultures against SARS-CoV-2, human coronavirus NL-63, and human coronavirus 229E, all very different human coronaviruses," the company said. This underlines the broad spectrum pan-coronavirus activity ...Benzinga · Oct 11, 2021

Company News for Sep 28, 2021Companies in the news are: BYND, RCAT, ITCI, NNVCZacks Investment Research · Sep 28, 2021

NNVCNanoViricides Inc.

NNVC

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any NNVC yet.

Related Tickers

Earnings

Mkt Cap

$34.8M

Volume

147.23K

Next Earnings

November 13th